Tavolimab ELISA Kit
PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human CD134 has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Tavolimab in the sample competitively binds to the pre-coated protein with biotin-labeled Tavolimab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Tavolimab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Product Specifications
Product Name Alternative
Tavolixizumab, MEDI0562, CAS: 1635395-25-3
Applications
Used for the quantitative determination of Tavolimab concentration in serum and plasma.
Stability
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Shipping Conditions
2-8 °C
Notes
For Research Use Only.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
VCX3A (Variable Charge X-linked Protein 3, VCX3, Variable Charge Protein on X with Eight Repeats, VCX8R, VCX-8r, Variably Charged Protein X-A, VCXA, VCX-A) (Biotin)
VCX3A (Variable Charge X-linked Protein 3, VCX3, Variable Charge Protein on X with Eight Repeats, VCX8R, VCX-8r, Variably Charged Protein X-A, VCXA, VCX-A) (Biotin)
